SARS-CoV-2 PCR – Page 15 – Communicable Diseases Research

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial

Letter

Published on 2020-07-292022-10-29
Journal: Trials [Category] COVID-19, SARS,

Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial

Letter

Published on 2020-07-022022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 1:1 aetiology agreement allocation Anosmia anticipated Arm ARMS Asymptomatic automatically Barcelona blinded block randomization Cardiac pathology change characterized chills clinical Clinical course clinical trial close contact collected Compound Concomitant conducted confirmed COVID-19 case Contact cough Course COVID-19 COVID-19 disease COVID-19 disease severity CRF criteria delivery determine diarrhoea dissemination double-blind Dyspnoea ECDC Effect Efficacy Efficacy and safety element EudraCT evaluate evaluate the effect Fever FIVE gestation global health HCQ headache history hospital Hospitalization Hydroxychloroquine hypersensitivity inclusion criteria intervention study investigator Liver disease Mild mild symptoms Mortality multicentre nasopharyngeal number objective oropharyngeal swab outcome packaged Pain participant Patient PCR PCR-confirmed Placebo placebo controlled trial placebo-controlled Pregnancy pregnant pregnant women prenatal Prevent Primary outcome progression protocol randomised randomised controlled trial Randomized receive recruited recruitment reducing Registered risk Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 viral shedding status stratified study group study participant Study protocol subsequent Symptom symptomatic syndrome Tablet Tolerability Transmission Treatment treatment group Trial Two-arm uterine website women
[DOI] 10.1186/s13063-020-04557-y PMC 바로가기 [Article Type] Letter

COVID-19 symptoms predictive of healthcare workers’ SARS-CoV-2 PCR results

의료 종사자의 SARS-CoV-2 PCR 결과를 예측하는 COVID-19 증상

Research Article

Published on 2020-06-262022-08-13
Journal: PLoS ONE [Category] COVID-19, Medicine and Health Sciences, MERS, SARS,

[키워드] 95% CI absence Accuracy Ageusia Anosmia Anosmia/ageusia assays Asymptomatic caused clinically contaminated surfaces coronavirus coronavirus 2019 disease COVID-19 COVID-19 symptom diagnostic Diagnostic accuracy disease exclusion Fever HCW HCWs healthcare healthcare worker Healthcare workers independent predictor initial less Loss of Smell loss of taste myalgia myalgias nasal nasal congestion nasopharyngeal Negative predictive value nine Patient performed positive Positive test Predictive Predictive value progression reported Retrospective study SARS-CoV-2 SARS-CoV-2 PCR sore throat Symptom Symptoms Taste temperature tested the strongest virus yielding
[DOI] 10.1371/journal.pone.0235460 PMC 바로가기 [Article Type] Research Article

Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories

Article

Published on 2020-06-162022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-032022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 95% CI absence addition administration of hydroxychloroquine Admission aerosol-generating procedures allergy analyzed Anesthesia antibody approved ARMS assigned balanced randomization blind Cancer Cantabria carried CDC Cell Chemoprophylaxis clinical Clinical data clinically coated Committee comparator Comparator group computer-generated control group Controlled Controlled clinical trial Controlled trial coronavirus COVID COVID-19 criteria CURB current detect Determination disease dissemination double blind double-blind dropout rate Efficacy Efficacy and safety element ELISA kit Emergency Endocrine estimate Ethics Euroimmun Evidence evidence of Germany GRADE greater group Health Health authority health-care healthcare personnel Healthcare professional healthcare professionals heart heart failure help hematological high risk hospital Hydroxychloroquine hydroxychloroquine sulfate hygiene Hypothesis ICU IDT IgA IgG IgM and IgG immune immunodeficiency in vitro incidence include Infection inhibit intensive care unit Intervention investigator kidney lactation liver measure Measures Medicine Negative PCR neurological New York number observation period outcome participant PCR performed Personal protective equipment Placebo positive positive SARS-CoV-2 PCR positive serology Pregnancy presenting Prevalence Primary outcome probes product professional Prophylaxis Prospective PROTECT Protective protocol Psychiatric randomised randomised controlled trial randomization Randomized randomized trial RCT receive recruitment reduce reported responsible risk RT-PCR Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR sequence Seroconversion serological serology severity Significant single center single-center study social distancing Spain Spanish Standard Statistical power status Study protocol subject Support Symptom symptomatic and asymptomatic Tablet Takara Taking Tamoxifen Transmission Treatment two-tailed university Vaccine virus website while
[DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Research

Published on 2020-06-012022-10-28
Journal: Annals of Intensive Care [Category] COVID-19,

[키워드] abdominal pain Acute myocarditis Admission afebrile Atypical C-reactive protein case sery Chest children Corticosteroid COVID-19 outbreak Critically ill discharge disease Ejection fraction elevated emerging disease Fever first symptom Host IL-6 receptor Immunological response increase in Inflammatory intensive care Intravenous immunoglobulin Intubated Kawasaki disease mechanism microbial monoclonal antibody Multisystem inflammatory syndrome myocarditis Paris pediatric performed positive procalcitonin receptor required Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR serology Shock skin rash Support survived systemic inflammation tertiary care center tomography Treatment ventricular while
[DOI] 10.1186/s13613-020-00690-8 PMC 바로가기 [Article Type] Research

The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19

Article

Published on 2020-03-252022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS,